基于CT的影像组学在预测门静脉高压患者门静脉压力及预后中的应用
研究在169例实验队列中基于肝脏、脾脏及联合影像组学特征建立无创预测门静脉压力(rPVP)的模型,并在62例胃食管静脉曲张治疗患者中验证;含肝脾联合特征的模型预测静脉曲张复发的最佳截断值为29.102 mmHg(AUC 0.866),rPVP与内镜治疗反应显著相关。
要点
- 基于CT肝脾联合影像组学特征可无创预测门静脉压力值。
- rPVP预测胃食管静脉曲张复发的最佳截断值为29.102 mmHg,AUC 0.866。
- rPVP与胃食管静脉曲张内镜治疗反应显著相关。
核心结论
- 门静脉压力值可通过基于CT的无创影像组学模型准确预测。
- rPVP可作为预测门静脉高压继发胃食管静脉曲张治疗结局的无创且精确的参考。
研究设计与样本
- 研究基于169例受试者的实验队列建立肝脏、脾脏及联合特征的影像组学门静脉压力(rPVP)模型。
- 从每个ROI提取影像组学特征并经LASSO回归降维以获得最优预测公式。
- 采用62例因胃食管静脉曲张接受治疗的患者作为验证队列,确认rPVP预测静脉曲张复发的效用。
诊断标准与关键数值
- 共推导出三个独立的门静脉压力预测公式,分别基于肝脏、脾脏及联合影像组学特征。
- 含肝脏和脾脏特征的模型对静脉曲张复发的预测能力最高,最佳截断值为29.102 mmHg(AUC 0.866)。
临床应用与阅片要点
- rPVP与患者对胃食管静脉曲张内镜治疗的反应显著相关。
- Kaplan-Meier分析进一步证实不同rPVP值患者之间存在差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Portal venous pressure (PVP) measurement is of clinical significance, especially in patients with portal hypertension. However, the invasive nature and associated complications limits its application. The aim of the study is to propose a noninvasive predictive model of PVP values based on CT-extracted radiomic features.
METHODS: Radiomics PVP (rPVP) models based on liver, spleen and combined features were established on an experimental cohort of 169 subjects. Radiomics features were extracted from each ROI and reduced via the LASSO regression to achieve an optimal predictive formula. A validation cohort of 62 patients treated for gastroesophageal varices (GOV) was used to confirm the utility of rPVP in predicting variceal recurrence. The association between rPVP and response to treatment was observed.
RESULTS: Three separate predictive formula for PVP were derived from radiomics features. rPVP was significantly correlated to patient response to endoscopic treatment for GOV. Among which, the model containing both liver and spleen features has the highest predictability of variceal recurrence, with an optimal cut-off value at 29.102 mmHg (AUC 0.866). A Kaplan Meier analysis further confirmed the difference between patients with varying rPVP values.
CONCLUSION: PVP values can be accurately predicted by a non-invasive, CT derived radiomics model. rPVP serves as a non-invasive and precise reference for predicting treatment outcome for GOV secondary to portal hypertension.
引用
- Tseng Y, Ma L, Li S, et al. Application of CT-based radiomics in predicting portal pressure and patient outcome in portal hypertension. Eur J Radiol. 2020. PMID: 32146345. doi:10.1016/j.ejrad.2020.108927
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。